MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Oxidative stress"

  • 2024 International Congress

    Role of Telemedicine- Versus Outpatient-Based Initiation And Management of Atkins Diet Therapy In Postmenopausal Women With Drug-Resistant Parkinson’s Disease During The COVID-19 Pandemic

    M. Sharma, S. Sinha (Pimpri, India)

    Objective: To explore the satisfaction, effectiveness, and safety of online modified Atkins diet (MAD) initiation and follow-up by comparing a group of work-from-home postmenopausal women…
  • 2024 International Congress

    Latent Genetic Architecture of Parkinson’s Disease Risk factors and Comorbidities

    J. Kim, I. Foote, S. Bandres-Ciga, 23. Research Team, C. Marshall, A. Grotzinger3, A. Singleton, A. Brentnall, C. Blauwendraat, A. Noyce, G. Genetics Program (London, United Kingdom)

    Objective: To comprehensively investigate the genetic relationship between Parkinson’s disease (PD), its risk factors, and comorbidities by constructing a factor model of the shared genetic…
  • 2024 International Congress

    A pathology-validated study to investigate the role of Uric Acid in Parkinson’s Disease

    P. Pecoraro, S. Carbone, V. Di Lazzaro, L. Di Biase (Rome, Italy)

    Objective: The aim of this study is to compare plasma uric acid levels between pathology-confirmed and clinically misdiagnosed Parkinson’s disease patients at a single-patient level.…
  • 2023 International Congress

    Impacts of mutations in Parkinson’s disease-related genes on telomere maintenance

    YH. Chen, CH. Lin, CK. Tseng (Taipei, Taiwan)

    Objective: To investigate the correlation between telomere length (TL) and Parkinson’s disease (PD), and whether the change in telomere biology participates in PD pathogenesis. Background:…
  • 2023 International Congress

    Parkin Coregulates Glutathione Metabolism in Adult Brain to Contribute to Redox Homeostasis

    D. El Kodsi, J. Tokarew, R. Sengupta, A. Chatterji, M. Takanashi, N. Hattori, J. Tomlinson (Ottawa, Canada)

    Objective: We sought to determine whether the expression of PRKN, a young-onset Parkinson disease-linked gene, confers redox homeostasis in vivo. Background: The mechanisms by which…
  • 2023 International Congress

    Identification of potential oxidative biomarkers in saliva of Parkinson’s disease patients

    J. Rungta, A. Roy, S. Choudhury, S. Ansari, P. Chatterjee, R. Khatun, R. Pramanik, S. Dey, H. Kumar (Kolkata, India)

    Objective: The goal of this study is to ascertain whether salivary oxidative markers are altered in Parkinson’s Disease (PD) and if there is an association of these markers with disease…
  • 2023 International Congress

    Estrogen derivatives and hydrogen peroxide as promising biomarkers in parkinson’s disease-preliminary results

    J. Sławek, P. Bastian, A. Roszmann, J. Dulski, D. Jacewicz, J. Drzezdzon, A. Kuban-Jankowska, M. Wozniak, N. Knap, T. Bączek, L. Konieczna, M. Belka, M. Gorska-Ponikowska (Gdańsk, Poland)

    Objective: The study aimed to identify biomarkers of early-stage neurodegeneration in Parkinson’s disease (PD). Background: The currently available diagnostic clinical criteria for PD enable diagnosis…
  • 2023 International Congress

    Effects of Eromomastax speciosa in a Gastric Ulcer in a 6-hydroxydopamine (6-OHDA)-induced Rat Model of Parkinson’s Disease.

    GL. Ndji Otto, P. Amang, H. Adjia (Bertoua, Cameroon)

    Objective: To investigate the extract of Eromomastax speciosa neuroprotective/gastroprotective potential in the indomethacin (IND)-induced gastric ulcer in a 6-hydroxydopamine (6-OHDA)-induced PD model. Background: Parkinson's disease…
  • 2023 International Congress

    Glycated alpha-synuclein and it emerging role in early onset of Parkinson’s disease

    S. Chatterjee, H. Thakkar, A. Khairnar, R. Shah (Gandhinagar, India)

    Objective: To elucidate, the molecular mechanism underlying glycated α-Syn mediated dopaminergic (DAergic) neurodegeneration in the substantia nigra (SN) via the AGE/RAGE signaling pathway. Background: Intracytoplasmic…
  • 2023 International Congress

    SLC1A7 mutation is a cause of the autosomal dominant form of Parkinson’s disease

    A. Kishore, M. Marc Sturm, F. Raimondi, P. Lichtner, A. Sreelatha, N. Casadei, C. Blauwendraat, G. Sarma, R. Kruger, A. Zimprich, A. Singleton, T. Gasser, O. Riess, M. Sharma (Kochi, India)

    Objective: To identify novel genes involved in the familial form of Parkinson’s disease (PD) in the Indian population. Background: Most of the familial forms of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 9
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley